Precision modulation of the gut microbiota, particularly reducing LPS-producing Gram-negative pathogens, represents a potential therapeutic target
Recalls & Warnings June 21, 2005 FTC Settles Claims with Marketers of FiberThin and Propolene On June 20, 2005, the Federal Trade Commission (FTC) announced that the marketers of the dietary supplements FiberThin and Propolene have settled FTC charges that their misleading weight-loss claims violated federal laws
Myers Cocktail A versatile IV therapy that addresses various health concerns, including fatigue, muscle recovery, and immune support
This demethylation specifically occurs at the promoter region of phosphoinositide-dependent protein kinase-1 (PDPK1), increasing its transcription
Luberda Z
Access practitioner portal Recognized for Quality